EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I

Nasir Saeed iD, Ole-Thomas Steiro iD, Jørund Langørgen, Hilde L Tjora iD, Rune O Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Tone M Norekvål, Trude Steinsvik iD, Kjell Vikenes iD, Torbjørn Omland und 1 weitere

Clinical Chemistry · 03.10.2024 · 70 (10) · 1241-1255

DOI: 10.1093/clinchem/hvae110 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Chemistry, online erschienen am 09.08.2024. Verfasst von Nasir Saeed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Chest Pain, Troponin I, Troponin T. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western Norway Regional Health Authority, Tom Wilhelmsen's Foundation, Siemens Healthineers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited data regarding the utility of follow-up cardiac troponin (cTn) measurements after admission for acute chest pain and how long-term stability of myocardial injury and prognostic value differ when using cardiac troponin T (cTnT) or I (cTnI).

Methods

We measured high-sensitivity (hs)-cTnT (Roche Diagnostics) and hs-cTnI (Siemens Healthineers) during hospitalization for acute chest pain and after 3 months. Acute myocardial injury was defined as concentrations > sex-specific upper reference limit (URL) during hospitalization and ≤URL at 3-months. Chronic myocardial injury (CMI) was defined as concentrations > URL at both time points. Patients were followed from the 3-month sampling point for a median of 1586 (IQR 1161–1786) days for a primary composite endpoint of all-cause mortality, myocardial infarction (MI), revascularization, and heart failure, and a secondary endpoint of all-cause mortality.

Results

Among 754 patients, 33.8% (hs-cTnT) and 19.2% (hs-cTnI) had myocardial injury during hospitalization. The rate of CMI was 5 times higher by hs-cTnT (20%) assay than hs-cTnI (4%), while acute myocardial injury was equally common; 14% (hs-cTnT) and 15% (hs-cTnI), respectively (6% and 5% when excluding index non-ST-elevation MI (NSTEMI). For hs-cTnT, peak index concentration, 3-month concentration and classification of CMI predicted the primary endpoint; hazard ratios (HRs) 1.38 (95% CI 1.20–1.58), 2.34 (1.70–3.20), and 2.31 (1.30–4.12), respectively. For hs-cTnI, peak index concentration predicted the primary endpoint; HR 1.14 (1.03–1.25). This association was nonsignificant after excluding index NSTEMI.

Conclusions

Acute myocardial injury is equally frequent, whereas CMI is more prevalent using hs-cTnT assay than hs-cTnI. Measuring hs-cTnT 3 months after an acute chest pain episode could assist in further long-term risk assessment. ClinicalTrials.gov Registration Number: NCT02620202

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chest PainTroponin ITroponin TAgedFemaleHumansMaleMiddle AgedBiomarkersCohort StudiesMyocardial InfarctionPrognosis

Substanzen

BiomarkersTroponin ITroponin T

Autor:innen und Institutionen

  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
  • Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Laboratory of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.
  • Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.

ORCID-Profile: Nasir Saeed, Ole-Thomas Steiro, Hilde L Tjora, Trude Steinsvik, Kjell Vikenes, Kristin M Aakre

Förderung

  • Western Norway Regional Health Authority
  • Tom Wilhelmsen's Foundation
  • Siemens Healthineers

Zitieren

APA

Saeed, N., Steiro, O. T., Langørgen, J., Tjora, H. L., Bjørneklett, R. O., Skadberg, Ø., Bonarjee, V. V. S., Mjelva, Ø. R., Norekvål, T. M., Steinsvik, T., Vikenes, K., Omland, T., & Aakre, K. M. (2024). Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I. Clinical Chemistry, 70(10), 1241-1255. https://doi.org/10.1093/clinchem/hvae110

Vancouver

Saeed N, Steiro OT, Langørgen J, Tjora HL, Bjørneklett RO, Skadberg Ø, et al. Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I. Clinical Chemistry. 2024;70(10):1241-1255. doi:10.1093/clinchem/hvae110

BibTeX
@article{Saeed2024,
  author = {Saeed, Nasir and Steiro, Ole-Thomas and Langørgen, Jørund and Tjora, Hilde L and Bjørneklett, Rune O and Skadberg, Øyvind and Bonarjee, Vernon V S and Mjelva, Øistein R and Norekvål, Tone M and Steinsvik, Trude and Vikenes, Kjell and Omland, Torbjørn and Aakre, Kristin M},
  title = {Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {10},
  pages = {1241--1255},
  doi = {10.1093/clinchem/hvae110}
}
Kostenlos starten →